Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precise Therapy for mCRPC Patients Through Whole Exome Sequencing

NCT04126915 is registered in ClinicalTrials.gov with Yinghao Sun as lead sponsor.

NCT NCT04126915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04126915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precise Therapy for mCRPC Patients Through Whole Exome Sequencing
Lead sponsor
Yinghao Sun
Phase
Observational
Overall status
Unknown status
Start date
November 8, 2019
Completion date
October 8, 2024
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostatic cancer